Utah Medical Products Net Income
| UTMD Stock | USD 64.51 2.12 3.40% |
As of the 10th of February, Utah Medical has the Semi Deviation of 1.1, risk adjusted performance of 0.1455, and Coefficient Of Variation of 566.68. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. Please validate Utah Medical Products treynor ratio, and the relationship between the standard deviation and downside variance to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 64.51 per share. Given that Utah Medical Products has jensen alpha of 0.1948, we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.
Utah Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Utah Medical's valuation are provided below:Utah Medical Products does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Utah Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Utah Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Utah Medical.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Utah Medical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Utah Medical Products or generate 0.0% return on investment in Utah Medical over 90 days. Utah Medical is related to or competes with Nyxoah, OraSure Technologies, Repro Med, InfuSystems Holdings, Neuronetics, Perspective Therapeutics, and Protalix Biotherapeutics. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry More
Utah Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Utah Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Utah Medical Products upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.36 | |||
| Information Ratio | 0.1096 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 |
Utah Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Utah Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Utah Medical's standard deviation. In reality, there are many statistical measures that can use Utah Medical historical prices to predict the future Utah Medical's volatility.| Risk Adjusted Performance | 0.1455 | |||
| Jensen Alpha | 0.1948 | |||
| Total Risk Alpha | 0.0915 | |||
| Sortino Ratio | 0.1121 | |||
| Treynor Ratio | 0.4871 |
Utah Medical February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1455 | |||
| Market Risk Adjusted Performance | 0.4971 | |||
| Mean Deviation | 1.13 | |||
| Semi Deviation | 1.1 | |||
| Downside Deviation | 1.36 | |||
| Coefficient Of Variation | 566.68 | |||
| Standard Deviation | 1.39 | |||
| Variance | 1.92 | |||
| Information Ratio | 0.1096 | |||
| Jensen Alpha | 0.1948 | |||
| Total Risk Alpha | 0.0915 | |||
| Sortino Ratio | 0.1121 | |||
| Treynor Ratio | 0.4871 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 | |||
| Downside Variance | 1.84 | |||
| Semi Variance | 1.22 | |||
| Expected Short fall | (1.21) | |||
| Skewness | (0.11) | |||
| Kurtosis | (0.42) |
Utah Medical Products Backtested Returns
Utah Medical appears to be very steady, given 3 months investment horizon. Utah Medical Products owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Utah Medical Products, which you can use to evaluate the volatility of the company. Please review Utah Medical's Coefficient Of Variation of 566.68, semi deviation of 1.1, and Risk Adjusted Performance of 0.1455 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Utah Medical holds a performance score of 14. The entity has a beta of 0.48, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Utah Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Utah Medical is expected to be smaller as well. Please check Utah Medical's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Utah Medical's existing price patterns will revert.
Auto-correlation | 0.55 |
Modest predictability
Utah Medical Products has modest predictability. Overlapping area represents the amount of predictability between Utah Medical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Utah Medical Products price movement. The serial correlation of 0.55 indicates that about 55.0% of current Utah Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 5.15 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Utah Medical Products reported net income of 13.87 M. This is 95.93% lower than that of the Health Care Equipment & Supplies sector and 86.08% lower than that of the Health Care industry. The net income for all United States stocks is 97.57% higher than that of the company.
Utah Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Utah Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Utah Medical could also be used in its relative valuation, which is a method of valuing Utah Medical by comparing valuation metrics of similar companies.Utah Medical is currently under evaluation in net income category among its peers.
Utah Fundamentals
| Return On Equity | 0.0954 | ||||
| Return On Asset | 0.0582 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 113.86 M | ||||
| Shares Outstanding | 3.19 M | ||||
| Shares Owned By Insiders | 7.17 % | ||||
| Shares Owned By Institutions | 70.36 % | ||||
| Number Of Shares Shorted | 99.06 K | ||||
| Price To Earning | 31.38 X | ||||
| Price To Book | 1.67 X | ||||
| Price To Sales | 5.19 X | ||||
| Revenue | 38.52 M | ||||
| Gross Profit | 22 M | ||||
| EBITDA | 17.06 M | ||||
| Net Income | 13.87 M | ||||
| Cash And Equivalents | 69.51 M | ||||
| Cash Per Share | 19.17 X | ||||
| Total Debt | 3.27 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 13.44 X | ||||
| Book Value Per Share | 37.43 X | ||||
| Cash Flow From Operations | 14.83 M | ||||
| Short Ratio | 7.17 X | ||||
| Earnings Per Share | 3.53 X | ||||
| Number Of Employees | 155 | ||||
| Beta | 0.35 | ||||
| Market Capitalization | 199.88 M | ||||
| Total Asset | 122.54 M | ||||
| Retained Earnings | 129.3 M | ||||
| Working Capital | 92.57 M | ||||
| Current Asset | 32.87 M | ||||
| Current Liabilities | 4.07 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.20 % | ||||
| Net Asset | 122.54 M | ||||
| Last Dividend Paid | 1.23 |
About Utah Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Utah Medical Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Utah Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Utah Medical Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.